Skip to content

Electrical stimulation and menstrual cramps: Is there a correlation between treatment time and pain relief?

Transcutaneous electrical nerve stimulation and primary dysmenorrhea syndrome: Is there a correlation between intervention time and pain relief?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3tzrxf
Enrollment
Unknown
Registered
2020-02-19
Start date
2019-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea

Interventions

Experimental group: 40 women with dysmenorrhea will be subjected to 40 minutes of transcutaneous electrical nerve stimulation. Control group: 40 women with dysmenorrhea will be subjected to 30 minutes
Other
E05.723.402

Sponsors

Centro Universitário de Barra Mansa
Lead Sponsor
SOBEU - Associação Barramansense de Ensino
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 35 years; pelvic pain caused by primary dysmenorrhea for more than 6 menstrual cycles; pelvic or transvaginal ultrasound image of at least 6 months without changes; deprivation of sexual intercourse one day before treatment; regular menstrual cycle between 21 and 35 days; be between the first and third day of the cycle; grades between 3 and 10 on the Visual Analog Pain Scale (VAS)

Exclusion criteria

Exclusion criteria: Age under 18 and over 35 years, use of analgesics and other therapies for pelvic pain or any systemic disease, alcohol consumption during menstrual cycle, gynecological disorders, undiagnosed abdominal pain, history of lower abdominal and pelvic surgery Pacemakers, Heart Pacemaker, Heart and Skin Diseases, Cancer, Pregnant, Mental Disorders, Breastfeeding, Grade EVA Less than 3, Painful When Clinic Is Not Open (Saturday, Sunday, 10 PM) and 7:00)

Design outcomes

Primary

MeasureTime frame
Pain below 3 according to visual analogue pain scale after treatment

Secondary

MeasureTime frame
Pain below 3 according to visual analogue pain scale two hours after treatment termination

Countries

Brazil

Contacts

Public ContactAriela Torres Cruz

Centro Universitário de Barra Mansa

ariela_tcruz@yahoo.com.br+55-024-992192494

Outcome results

None listed

Source: REBEC (via WHO ICTRP)